Penicillin allergy labels may fuel superbugs, study warns

NCT ID NCT07177690

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study looks at how having a penicillin allergy record affects treatment and antibiotic resistance in patients hospitalized with COVID-19. Many people labeled as allergic to penicillin are not truly allergic, leading to use of less effective antibiotics that can drive resistance. Researchers will compare outcomes and resistance genes in patients with and without a penicillin allergy label, and see if removing incorrect labels reduces resistance.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this study could show that removing incorrect penicillin allergy labels reduces antibiotic resistance, leading to better treatment guidelines and fewer treatment failures.

What could go wrong

This is an observational study, not a treatment trial, so it won't directly change patient care. Results may not apply to all settings, and the sample size is modest.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COVID-19 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

COVID-19 drug allergy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Leeds Teaching Hospitals NHS trust

    Leeds, United Kingdom